BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 30485119)

  • 1. Methylglyoxal induces retinopathy-type lesions in the absence of hyperglycemia: studies in a rat model.
    Schlotterer A; Kolibabka M; Lin J; Acunman K; Dietrich N; Sticht C; Fleming T; Nawroth P; Hammes HP
    FASEB J; 2019 Mar; 33(3):4141-4153. PubMed ID: 30485119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD74 indicates microglial activation in experimental diabetic retinopathy and exogenous methylglyoxal mimics the response in normoglycemic retina.
    Wang J; Lin J; Schlotterer A; Wu L; Fleming T; Busch S; Dietrich N; Hammes HP
    Acta Diabetol; 2014 Oct; 51(5):813-21. PubMed ID: 24974304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor α protects capillary pericytes in the retina.
    Ding L; Cheng R; Hu Y; Takahashi Y; Jenkins AJ; Keech AC; Humphries KM; Gu X; Elliott MH; Xia X; Ma JX
    Am J Pathol; 2014 Oct; 184(10):2709-20. PubMed ID: 25108226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against methylglyoxal-derived AGEs by regulation of glyoxalase 1 prevents retinal neuroglial and vasodegenerative pathology.
    Berner AK; Brouwers O; Pringle R; Klaassen I; Colhoun L; McVicar C; Brockbank S; Curry JW; Miyata T; Brownlee M; Schlingemann RO; Schalkwijk C; Stitt AW
    Diabetologia; 2012 Mar; 55(3):845-54. PubMed ID: 22143324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fractalkine-induced microglial vasoregulation occurs within the retina and is altered early in diabetic retinopathy.
    Mills SA; Jobling AI; Dixon MA; Bui BV; Vessey KA; Phipps JA; Greferath U; Venables G; Wong VHY; Wong CHY; He Z; Hui F; Young JC; Tonc J; Ivanova E; Sagdullaev BT; Fletcher EL
    Proc Natl Acad Sci U S A; 2021 Dec; 118(51):. PubMed ID: 34903661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extract of Polygonum cuspidatum Attenuates Diabetic Retinopathy by Inhibiting the High-Mobility Group Box-1 (HMGB1) Signaling Pathway in Streptozotocin-Induced Diabetic Rats.
    Sohn E; Kim J; Kim CS; Lee YM; Kim JS
    Nutrients; 2016 Mar; 8(3):140. PubMed ID: 26950148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal overexpression of angiopoietin-2 mimics diabetic retinopathy and enhances vascular damages in hyperglycemia.
    Pfister F; Wang Y; Schreiter K; vom Hagen F; Altvater K; Hoffmann S; Deutsch U; Hammes HP; Feng Y
    Acta Diabetol; 2010 Mar; 47(1):59-64. PubMed ID: 19238311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral carnosine supplementation prevents vascular damage in experimental diabetic retinopathy.
    Pfister F; Riedl E; Wang Q; vom Hagen F; Deinzer M; Harmsen MC; Molema G; Yard B; Feng Y; Hammes HP
    Cell Physiol Biochem; 2011; 28(1):125-36. PubMed ID: 21865855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRPC proteins contribute to development of diabetic retinopathy and regulate glyoxalase 1 activity and methylglyoxal accumulation.
    Sachdeva R; Schlotterer A; Schumacher D; Matka C; Mathar I; Dietrich N; Medert R; Kriebs U; Lin J; Nawroth P; Birnbaumer L; Fleming T; Hammes HP; Freichel M
    Mol Metab; 2018 Mar; 9():156-167. PubMed ID: 29373286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of pericyte loss by trolox in diabetic rat retina.
    Ansari NH; Zhang W; Fulep E; Mansour A
    J Toxicol Environ Health A; 1998 Jul; 54(6):467-75. PubMed ID: 9661912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.
    Kern TS; Tang J; Mizutani M; Kowluru RA; Nagaraj RH; Romeo G; Podesta F; Lorenzi M
    Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3972-8. PubMed ID: 11053301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose erythropoietin inhibits oxidative stress and early vascular changes in the experimental diabetic retina.
    Wang Q; Pfister F; Dorn-Beineke A; vom Hagen F; Lin J; Feng Y; Hammes HP
    Diabetologia; 2010 Jun; 53(6):1227-38. PubMed ID: 20339831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleoside diphosphate kinase B deficiency causes a diabetes-like vascular pathology via up-regulation of endothelial angiopoietin-2 in the retina.
    Qiu Y; Zhao D; Butenschön VM; Bauer AT; Schneider SW; Skolnik EY; Hammes HP; Wieland T; Feng Y
    Acta Diabetol; 2016 Feb; 53(1):81-9. PubMed ID: 25900369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinopathy is reduced during experimental diabetes in a mouse model of outer retinal degeneration.
    de Gooyer TE; Stevenson KA; Humphries P; Simpson DA; Gardiner TA; Stitt AW
    Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5561-8. PubMed ID: 17122149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes-enhanced tumor necrosis factor-alpha production promotes apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy.
    Behl Y; Krothapalli P; Desta T; DiPiazza A; Roy S; Graves DT
    Am J Pathol; 2008 May; 172(5):1411-8. PubMed ID: 18403591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dicarbonyl stress and apoptosis of vascular cells: prevention by alphaB-crystallin.
    Nagaraj RH; Oya-Ito T; Bhat M; Liu B
    Ann N Y Acad Sci; 2005 Jun; 1043():158-65. PubMed ID: 16037235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperglycemia attenuates acute permeability response to advanced glycation end products in retinal microvasculature.
    Warboys CM; Fraser PA
    Microvasc Res; 2010 Jul; 80(1):174-6. PubMed ID: 20302881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceleration of experimental diabetic retinopathy in the rat by omega-3 fatty acids.
    Hammes HP; Weiss A; Führer D; Krämer HJ; Papavassilis C; Grimminger F
    Diabetologia; 1996 Mar; 39(3):251-5. PubMed ID: 8721768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miRNA-124 Prevents Rat Diabetic Retinopathy by Inhibiting the Microglial Inflammatory Response.
    Chen Y; Schlotterer A; Kurowski L; Li L; Dannehl M; Hammes HP; Lin J
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology.
    Kern TS; Miller CM; Du Y; Zheng L; Mohr S; Ball SL; Kim M; Jamison JA; Bingaman DP
    Diabetes; 2007 Feb; 56(2):373-9. PubMed ID: 17259381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.